Polaryx Therapeutics, Inc. PLYX Convertible Preferred Stock Outstanding Shares

Convertible Preferred Stock Outstanding Shares at other companies

Ralliant CorporationRAL

0—

RBC BearingsRBC

0—

Henry ScheinHSIC

0—

SBA CommunicationsSBAC

0—

Lantheus HoldingsLNTH

0—

TPG Inc.TPG

0—

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Operating cash flow-$2.1M-191%

Market cap$115.64M—

Return on equity-1,209.8%—

Current ratio3.5×—

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Polaryx Therapeutics, Inc. 's convertible preferred stock outstanding shares?: Polaryx Therapeutics, Inc. (PLYX) reported convertible preferred stock outstanding shares of 0 in Q4 2025.
What does convertible preferred stock outstanding shares mean?: This represents the number of convertible preferred shares currently held by all shareholders, excluding any shares held in treasury. It is the primary figure used to calculate the impact of preferred stock on earnings per share and voting power. It reflects the actual equity stake held by preferred investors.